Sarcopenia, peripheral neuropathy, and peripheral arterial disease in patients with diabetes mellitus under hemodialysis

被引:0
|
作者
Bustamante Hernandez, Martha Beatriz [1 ]
Garduno Garcia, Jose de Jesus [1 ]
Montenegro Morales, Laura Patricia [2 ]
Camarillo Romero, Eneida del Socorro [2 ]
Huitron Bravo, Gerardo [2 ]
Camarillo Romero, Maria del Socorro [2 ]
机构
[1] Univ Autonoma Estado Mexico UNAM, Fac Med, Mexico City, DF, Mexico
[2] Univ Autonoma Estado Mexico UNAM, Fac Quim, Mexico City, DF, Mexico
来源
关键词
sarcopenia; peripheral neuropathy; peripheral arterial disease; diabetes mellitus; renal dialysis; hemodialysis; TYPE-2; DIAGNOSIS; CONSENSUS; EXERCISE; INDEX;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Sarcopenia is characterized by loss of strength and muscle mass. Patients with diabetes mellitus who are under hemodialysis treatment show decreased physical activity and changes in their food intake, which also leads to the presence of sarcopenia. On the other hand, peripheral neuropathy and peripheral arterial disease commonly appear as chronic complications of diabetes mellitus. Methods: A cross-sectional, observational study was carried out in diabetes mellitus patients on hemodialysis. For the assessment of sarcopenia, muscle strength, physical performance and muscle mass percentage were measured. Muscle strength was calculated with a dynamometer, while physical performance was evaluated in seconds by means of a walk test with a stopwatch; muscle mass percentage was obtained using a scale with bioelectrical impedance. Sarcopenia was considered severe when there was low muscle strength and percentage in addition to low physical performance. Peripheral neuropathy was assessed by exploring touch and pressure sensibility with the Semmes-Weinstein monofilament test and deep sensibility with a 128 Hz tuning fork. The ankle-brachial index was the measurement taken for the peripheral arterial disease classification. Results: The final analysis was performed with 33 patients, whose time on hemodialysis was 3.57 +/- 2.56 years. The prevalence of severe sarcopenia and sarcopenia was 90.8% and that of pre-sarcopenia was 9% of all patients. On the other hand, 78.1% were found to be patients with loss of deep sensibility, while the percentage of patients with loss of sensibility to pressure and touch was 54.5%. A correlation was found between the sarcopenia parameters and the time of evolution of renal failure and age. Conclusion: Sarcopenia occurs, in its different stages, in practically all diabetes mellitus patients undergoing hemodialysis; there is a relationship with the patient's age and hemodialysis time.
引用
收藏
页码:151 / 158
页数:8
相关论文
共 50 条
  • [1] Peripheral arterial disease in patients with diabetes mellitus
    Mowla, Ashkan
    Bahrami, Amir
    Dastgheib, Seyed Alireza
    SOUTHERN MEDICAL JOURNAL, 2006, 99 (07) : 707 - 708
  • [2] Peripheral arterial disease in patients with diabetes mellitus
    Hamish, M.
    Gohel, M. S.
    Davies, A. H.
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (10) : 570 - 574
  • [3] The significance of peripheral arterial disease in patients with diabetes mellitus
    Diehm, C.
    Schwertfeger, M.
    Kirch, W.
    Pittrow, D.
    DIABETOLOGE, 2009, 5 (01): : 12 - 18
  • [4] Peripheral arterial disease in diabetes mellitus
    Schmitt, Volker H.
    Keller, Karsten
    Espinola-Klein, Christine
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2022, 147 (22) : 1433 - 1436
  • [5] Screening for peripheral neuropathy and peripheral arterial disease in persons with diabetes mellitus in a Nigerian University Teaching Hospital
    Ogbera A.O.
    Adeleye O.
    Solagberu B.
    Azenabor A.
    BMC Research Notes, 8 (1)
  • [6] Increased prevalence of peripheral arterial disease in patients with obese sarcopenia undergoing hemodialysis
    Tian, Shun-Li
    Zhang, Kai
    Xu, Peng-Cheng
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (06) : 5148 - 5152
  • [7] Iloprost in the management of peripheral arterial disease in patients with diabetes mellitus
    Piaggesi, A.
    Vallini, V.
    Iacopi, E.
    Tedeschi, A.
    Scatena, A.
    Goretti, C.
    Rizzo, L.
    MINERVA CARDIOANGIOLOGICA, 2011, 59 (01): : 101 - 108
  • [8] The evaluation of cardiac and peripheral arterial disease in patients with diabetes mellitus
    Shen, Rhuna
    Wiegers, Susan E.
    Glaser, Ruchira
    ENDOCRINE RESEARCH, 2007, 32 (3-4) : 109 - 142
  • [9] Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus
    Dobrica, Elena-Codruta
    Cozma, Matei Alexandru
    Gaman, Mihnea-Alexandru
    Gaman, Amelia Maria
    Stanescu, Ana Maria Alexandra
    Iancu, Adela Mihaela
    Motofei, Ion
    Diaconu, Camelia Cristina
    PROCEEDINGS OF THE 35TH BALKAN MEDICAL WEEK, 2018, : 42 - 47
  • [10] Peripheral Arterial Disease in Patients with Type 2 Diabetes Mellitus
    Rhee, Sang Youl
    Kim, Young Seol
    DIABETES & METABOLISM JOURNAL, 2015, 39 (04) : 283 - 290